Form 4 for WST West Pharmaceutical Services
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001127602-24-007020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | WST | Abraham Silji | SVP, CTO | M - OptEx | $173.22 | +7,012 | 11.7K | +150% | +$1.21M |
| D | 2024-02-27 | 2024-02-23 | WST | Abraham Silji | SVP, CTO | S - Sale+OE | $365.00 | -7,012 | 4,660 | -60% | -$2.56M |
| D | 2024-02-27 | 2024-02-23 | WST | Abraham Silji | SVP, CTO | M - OptEx | $0.00 | -7,012 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | M | A | 7,012 | $173.22 | 11,672.26 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-23 | S | D | 7,012 | $365.00 | 4,660.26 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-02-23 | M | D | 7,012 | $0.00 | 0 | D | $173.22 · 2021-02-18 to 2030-02-18 | 7,012 Stock Options (Right to Buy) | (F1) This award vests in four equal annual installments beginning on February 18, 2021. |